The price of the printed version of pomadotamine is about 2000 yuan, but it is not qualified for domestic listing, and the purchase channel is opaque, so it is difficult to tell whether the product is true or false. However, with the listing of pomadamide made in China, and on February 3, 2002 1,1,Anyue pomadamide recently successfully entered the medical insurance catalogue, which took effect on June 38+0, 2022, further improving the accessibility and fairness of drugs, ensuring the transparency of purchase channels and the effectiveness of product quality consistency evaluation.